RealNetworks (RNWK) Reports Q4 Loss of $0.17, Revenues Beat
Get Alerts RNWK Hot Sheet
Price: $0.73 --0%
EPS Growth %: +100.0%
Financial Fact:
Interest income, net: 119K
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +100.0%
Financial Fact:
Interest income, net: 119K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
RealNetworks (NASDAQ: RNWK) reported Q4 EPS of ($0.17), versus ($0.18) reported last year. Revenue for the quarter came in at $43.4 million versus the consensus estimate of $33.11 million.
Fourth Quarter 2019 Financial Highlights
- Revenue was $43.4 million (inclusive of $26.1 million from Napster) compared to $45.0 million (inclusive of $27.3 million from Napster) in the prior quarter and $16.6 million in the prior year period.
- Games revenue was $6.6 million, down 8% compared to $7.2 million in the prior quarter and up 17% compared to $5.6 million in the prior year period.
- Gross profit margin was 43%, up from 42% in the prior quarter and down from 77% in the prior year period. Napster\'s gross profit margin for the fourth quarter of 2019 was 21%, while RealNetworks\' gross profit margin without Napster was 76%.
- Operating expenses decreased $0.4 million, or 2%, from the prior quarter and increased $6.2 million, or 34%, from the prior year period. Napster\'s operating expenses were $7.1 million for the fourth quarter of 2019.
- Net loss attributable to RealNetworks was $(6.4) million, or $(0.17) per diluted share, compared to net loss of $(6.0) million, or $(0.16) per diluted share, in the prior quarter and a net loss of $(6.9) million, or $(0.18) per diluted share, in the prior year period.
- Adjusted EBITDA was a loss of $(2.7) million compared to a loss of $(3.2) million in the prior quarter and a loss of $(4.1) million in the prior year period.
For earnings history and earnings-related data on RealNetworks (RNWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!